Global Neuro-Behçet’s Disease Treatment Market, By Symptoms (Brainstem Syndrome, Multiple-Sclerosis like Presentations, Movement Disorders, Meningoencephalitic Syndrome, Myelopathic Syndrome, Cerebral Venous Sinus Thrombosis (CVST), and Intracranial Hypertension), Forms (Parenchymal and Non-Parenchymal), Treatment (Corticosteroids, Immunosuppressive Agents, Immunomodulators, Phosphodiesterase 4 (PDE4) Inhibitor, Interleukin-1β blocker and Others), Route Of Administration (Oral, Injectable), End Use (Hospitals, Homecare, Specialty Clinics, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of the Middle East and Africa) Industry Trends and Forecast to 2028